1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsSupports the transition of promising novel technologies for basic and clinical cancer research from the development stage to validation and widespread application.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Higher Education Institutions, nonprofits, for-profit organizations, and public/state entities. Confirm the full requirements in the official notice before applying.
The current listing shows up to $300,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) are due November 10, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) is funded by National Institutes of Health (NIH) - National Cancer Institute (NCI). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Supplemental Funding Requests to Support Super Intelligence (SI) Innovation in the Presidential SI Challenge is sponsored by National Science Foundation (NSF Directorates for EDU and TIP). Provides supplemental support for active NSF awardees to develop hands-on and experiential learning edtech opportunities, tools, and systems that foster student proficiency in advanced technologies across middle and high schools.
Small Business Innovation Research and Small Business Technology Transfer Programs Phase II is sponsored by National Institute of Food and Agriculture (USDA). Phase II funding for prior USDA SBIR/STTR Phase I awardees to advance R&D toward commercialization in agriculture, food, rural development, biofuels, and related areas. Supports scientific excellence and commercial application.
PAR-27-062 creates a three-year, $80,000-salary postdoctoral career award across NCI, NIAID, NIBIB, NIDCR and NINDS — and it carries a hard eligibility window that closes two years after you start your postdoc. Full analysis of the Academic Career Excellence Award, what it replaces, and why the timing rule is the whole competition.
Read articleNIH's RFI on administrative burden (NOT-OD-26-118) takes comments through December 8, 2026. It asks seven questions, lists eight reforms already made, and warns that responses may be posted unredacted. Here is what NIH is really asking for, what it can and cannot change alone, and how researchers and research offices should respond.
Read articleOn November 2, 2026, NIH released NOT-OD-27-006, a draft update to its Policy for Data and Safety Monitoring. As summarized by Harvard's research integrity office, the draft would extend risk-based monitoring from clinical trials to all NIH-supported clinical research, drop the blanket DSMB requirement for Phase 3 and multi-site trials, and require an NIH-approved monitoring plan scaled to risk, effective for applications six months after the final policy. Comments are due January 6, 2027. What it changes and how to respond.
Read article